Company intelligence / Profile preview

Barcode Nanotech

Nazareth, Northern District, Israel

Ownership: Private
Employees: ~6
Development stage: Other

Overview

Barcode Nanotech is developing selective delivery vehicles for RNA/DNA-based drugs using proprietary lipid-based nanoparticles identified through a proprietary in vivo and AI-based screening platform

Therapeutic areas: Oncology
Modalities: Lipid nanoparticle delivery therapyRNA therapy
Industry: Biotech

Partnerships

Pharma companies (partnerships mentioned but not specifically named)

Beyond the preview

Go deeper on Barcode Nanotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Barcode Nanotech.

Explore the full profile